Charles Schwab’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-718,138
| Closed | -$3.07M | – | 3211 |
|
|
2019
Q3 | $3.07M | Buy |
718,138
+493,919
| +220% | +$1.79M | ﹤0.01% | 2217 |
|
|
2019
Q2 | $669K | Buy |
224,219
+191,157
| +578% | +$479K | ﹤0.01% | 2704 |
|
|
2019
Q1 | $58K | Sell |
33,062
-32,088
| -49% | -$44.3K | ﹤0.01% | 3108 |
|
|
2018
Q4 | $55K | Buy |
+65,150
| New | +$77.7K | ﹤0.01% | 3129 |
|
|
2018
Q3 | – | Sell |
-28,381
| Closed | -$24K | – | 3151 |
|
|
2018
Q2 | $24K | Sell |
28,381
-181,900
| -87% | -$176K | ﹤0.01% | 3110 |
|
|
2018
Q1 | $289K | Hold |
210,281
| – | – | ﹤0.01% | 2890 |
|
|
2017
Q4 | $213K | Sell |
210,281
-173,519
| -45% | -$196K | ﹤0.01% | 2973 |
|
|
2017
Q3 | $584K | Buy |
383,800
+97,900
| +34% | +$164K | ﹤0.01% | 2674 |
|
|
2017
Q2 | $532K | Hold |
285,900
| – | – | ﹤0.01% | 2668 |
|
|
2017
Q1 | $375K | Buy |
285,900
+201,900
| +240% | +$164K | ﹤0.01% | 2747 |
|
|
2016
Q4 | $59K | Hold |
84,000
| – | – | ﹤0.01% | 3065 |
|
|
2016
Q3 | $94K | Hold |
84,000
| – | – | ﹤0.01% | 3016 |
|
|
2016
Q2 | $121K | Buy |
84,000
+59,000
| +236% | +$68.4K | ﹤0.01% | 3040 |
|
|
2016
Q1 | $25K | Hold |
25,000
| – | – | ﹤0.01% | 3043 |
|
|
2015
Q4 | $81K | Hold |
25,000
| – | – | ﹤0.01% | 3055 |
|
|
2015
Q3 | $78K | Hold |
25,000
| – | – | ﹤0.01% | 3053 |
|
|
2015
Q2 | $88K | Buy |
+25,000
| New | +$107K | ﹤0.01% | 3055 |
|
Charles Schwab's CVRS Position: Q4 2019 in Review
Charles Schwab sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 718,138 shares — an estimated $3.07M sold.
Charles Schwab first reported a position in CVRS in Q2 2015 and held it in 17 quarters. The position peaked at $3.07M in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Charles Schwab reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Charles Schwab sold 718,138 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $3.07M.
- Charles Schwab first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 17 quarters.
- Charles Schwab's CORINDUS VASCULAR ROBOTICS, INC position peaked at $3.07M in Q3 2019.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.